Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

TACKLING ANTIBIOTIC OVER-PRESCRIPTION

Project description

A boost for personalised antibiotic treatment

In the dynamic realm of healthcare diagnostics, researchers are spearheading a transformative initiative. Annually, hundreds of millions individuals seek medical attention for urinary ract infections (UTIs), necessitating precise antibiotic prescriptions. Yet, pinpointing the ideal treatment proves challenging, exacerbated by surging antibiotic resistance rates. In this context, the EU-funded OVER-AB project is designing a point-of-care diagnostic tool. Empowering physicians, this innovation permits swift assessment of the effectiveness of antibiotics prior to administration. Results are swift, precise, and tailored, augmenting treatment efficiency. The project’s pioneering spirit champions a future where personalised patient care reigns. As a female-led initiative, it is also inspiring women to embrace entrepreneurship with unwavering passion and determination.

Objective

Within the ever changing and ever innovative field of healthcare diagnostics, ShanX Medtech and Dr. Sophia Eriola Shanko are dedicated to bringing personalised diagnostic testing to the point-of-care, ensuring the timely and appropriate administration of antibiotics to patients.

Worldwide over 400 million people visit their doctor with a Urinary Tract Infection (UTI) every year. With the majority of UTIs stemming from a bacterial infection, the treatment thereof is straightforward: an antibiotic prescription. However, for physicians determining the correct antibiotic treatment for each patient remains problematic. Furthermore, the global increase in antibiotic resistance rates reinforces the need to improve antibiotic prescription protocols. ShanX is developing a diagnostic tool that can be used at the doctor's premises and it allows the physician to test a series of antibiotics prior to administration, thereby ensuring the subsequent treatment efficacy. The results provided are fast, accurate, and tailored to each individual patient.

ShanX Medtech is revolutionizing the antibiotic treatment workflow by enabling fast, evidence-based and personalized antibiotic administration.

Sophia is proudly building a world where women, like herself, are defining and designing a better future for patient care. She hopes that her positivity and charisma serve as an inspiration to others, and that – while leading by example – true passion paired with determination and grit, can empower women to meet their potential and pursue entrepreneurship.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-CSA - HORIZON Coordination and Support Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIE-2022-SCALEUP-02

See all projects funded under this call

Coordinator

SHANX MEDTECH B.V.
Net EU contribution
€ 75 000,00
Address
HIGH TECH CAMPUS 41
5656 AE Eindhoven
Netherlands
Region
Zuid-Nederland Noord-Brabant Zuidoost-Noord-Brabant
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
No data